Indira IVF, a leading fertility treatment provider, has temporarily withdrawn its plans for a ₹3,500 crore initial public offering (IPO) after concerns raised by the Securities and Exchange Board of India (SEBI). The regulator questioned the timing of a biopic on the company’s founder, which was released shortly after the confidential filing of the IPO. The development …